Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1
about
Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.Current State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases.Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.From catalysts to bioactive organometallics: do Grubbs catalysts trigger biological effects?Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems.cis,fac-Dichlorido{N-[3,5-di-tert-butyl-2-(trimethyl-silyl-oxy)benz-yl]-N,N-bis-(2-pyridylmeth-yl)amine}(dimethyl sulfoxide)ruthenium(II) dichloro-methane disolvate.Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.A study on the inhibition of dihydrofolate reductase (DHFR) from Escherichia coli by gold(i) phosphane compounds. X-ray crystal structures of (4,5-dichloro-1H-imidazolate-1-yl)-triphenylphosphane-gold(i) and (4,5-dicyano-1H-imidazolate-1-yl)-triphenInsights on the binding ability of a new adenine analog: 7-amine-1,2,4-triazolo[1,5-a]pyrimidine. Synthesis and magnetic study of the first copper(ii) complexesDinuclear silver(i) complexes for the design of metal–ligand networks based on triazolopyrimidinesThe Spectroscopic and Conductive Properties of Ru(II) Complexes with Potential Anticancer Properties
P2860
Q36032742-1C784883-666B-48F0-A3FC-59166CBEABE8Q38669290-4D7B72D3-7C67-4D03-9651-010E6B5F13DDQ38776872-C5DD24EF-81B0-49FE-8EB4-5D1FE68855F0Q39208851-A7F7C947-A1FA-4DAD-AF07-13DE12D66764Q39229950-47F575BC-5F03-4FFD-A4BC-B8F9CCFA7994Q39477359-A2FC28CD-7A7A-4F12-BD54-7C4BD6C0F133Q40759010-DFBE3880-7781-4B1C-9D24-FD81158DF726Q42123575-39F8613E-2B16-4CC5-9E82-CA743C06D379Q49860442-645BA702-8C05-481C-9966-880F3325876FQ52787987-91CEE799-EFAE-41CD-9EE9-D99BB57A8E93Q58863955-EAB796B7-C3B7-4B2C-9E50-66EC404C5237Q58863966-17E76592-5A28-4FC2-93DB-78CC9717E8CAQ59062348-52F61E47-5519-4B93-83E2-0F82BDF0875F
P2860
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Synthesis and chemical-pharmac ...... 5,7-dimethyl[1,2,4]triazolo[1
@ast
Synthesis and chemical-pharmac ...... 5,7-dimethyl[1,2,4]triazolo[1
@en
type
label
Synthesis and chemical-pharmac ...... 5,7-dimethyl[1,2,4]triazolo[1
@ast
Synthesis and chemical-pharmac ...... 5,7-dimethyl[1,2,4]triazolo[1
@en
prefLabel
Synthesis and chemical-pharmac ...... 5,7-dimethyl[1,2,4]triazolo[1
@ast
Synthesis and chemical-pharmac ...... 5,7-dimethyl[1,2,4]triazolo[1
@en
P2093
P50
P356
P1476
Synthesis and chemical-pharmac ...... 5,7-dimethyl[1,2,4]triazolo[1
@en
P2093
Alberta Bergamo
Claudia Casarsa
Ennio Zangrando
Jaap G Haasnoot
Moreno Cocchietto
Sonia Zorzet
P304
P356
10.1021/JM030984D
P407
P577
2004-02-01T00:00:00Z